Vela secures license for Swift's myT Primer technology

12/12/2012 | Xconomy

Vela Diagnostics has struck a nonexclusive licensing deal with Swift Biosciences. The deal, whose terms were not made public, allows Vela to integrate Swift's myT Primer system with its assays for cancer diagnosis.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT